Int J Ophthalmol. 2017 Apr 18;10(4):550-554. doi: 10.18240/ijo.2017.04.08. eCollection 2017.
Expression and role of specificity protein 1 in the sclera remodeling of experimental myopia in guinea pigs.
International journal of ophthalmology
Bo Jiang, Zhang-You Wu, Zi-Cheng Zhu, Gen-Jie Ke, Yue-Chun Wen, Si-Qin Sun
Affiliations
Affiliations
- Department of Ophthalmology, Anhui Provincial Hospital, Anhui Medical University, Hefei 230001, Anhui Province, China.
PMID: 28503426
PMCID: PMC5406631 DOI: 10.18240/ijo.2017.04.08
Abstract
AIM: To study the expression of collagen I and transcription factor specificity protein 1 (Sp1), a transforming growth factor-β1 (TGF-β1) downstream target, and reveal the impact of the TGF-β1-Sp1 signaling pathway on collagen remodeling in myopic sclera.
METHODS: Seventy-five 1-week-old guinea pigs were randomly divided into normal control, form deprivation myopia (FDM), and self-control groups. FDM was induced for different times using coverage with translucent latex balloons and FDM recovery was performed for 1wk after 4wk treatment; then, changes in refractive power and axial length were measured. Immunohistochemistry and reverse transcription-polymerase chain reaction were used to evaluate dynamic changes in collagen I and Sp1 expression in the sclera of guinea pigs with emmetropia and experimental myopia, and the relationship between collagen I and Sp1 levels was analyzed.
RESULTS: In the FDM group, the refractive power was gradually changed (from 2.09±0.30 D at week 0 to -1.23±0.69 D, -4.17±0.59 D, -7.07±0.56 D, and -4.30±0.58 D at weeks 2, 4, 6, and 1wk after 4wk, respectively;
CONCLUSION: Our data indicate that transcription factor Sp1 may be involved in the regulation of type I collagen synthesis/degradation during myopic sclera remodeling, suggesting that TGF-β1 signaling plays a role in the development and progression of myopia.
Keywords: collagen I; form-deprivation myopia; sclera remodeling; specificity protein 1; transforming growth factor-β1
References
- Front Oncol. 2016 Mar 21;6:61 - PubMed
- J Ophthalmol. 2016;2016:5126560 - PubMed
- J Biol Chem. 2004 Apr 30;279(18):18121-6 - PubMed
- Int J Clin Exp Med. 2015 Nov 15;8(11):20355-67 - PubMed
- Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Apr;34(4):349-55 - PubMed
- Int J Ophthalmol. 2015 Feb 18;8(1):39-45 - PubMed
- JAMA. 2015 Sep 15;314(11):1142-8 - PubMed
- Eye (Lond). 2016 Jun;30(6):796-804 - PubMed
- Exp Eye Res. 2009 Mar;88(3):458-66 - PubMed
- Exp Eye Res. 2009 Jun 15;89(1):101-8 - PubMed
- Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Nov;21(6):679-82 - PubMed
- PLoS One. 2015 Jan 13;10(1):e0115524 - PubMed
- Mol Vis. 2014 Jul 02;20:977-87 - PubMed
- J Huazhong Univ Sci Technolog Med Sci. 2007 Oct;27(5):601-4 - PubMed
- J Biol Chem. 2003 May 9;278(19):16587-94 - PubMed
- FEBS J. 2015 Jan;282(2):224-58 - PubMed
Publication Types